We are live on ! Find out more
LS

Livforsakringsbolaget Skandia Portfolio holdings

AUM $2.58B
1-Year Est. Return 30.64%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+30.64%
3 Year Est. Return
+115.62%
5 Year Est. Return
+153.42%
10 Year Est. Return
+554.99%
AUM
$145M
AUM Growth
+$5.78M
Cap. Flow
-$1.43M
Cap. Flow %
-0.99%
Top 10 Hldgs %
23.91%
Holding
187
New
12
Increased
18
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.22M
2
UTHR icon
United Therapeutics
UTHR
+$760K
3
F icon
Ford
F
+$723K
4
HUM icon
Humana
HUM
+$679K
5
CB icon
Chubb
CB
+$539K

Sector Composition

Rank Sector Weight
1 Healthcare 18.66%
2 Technology 17.87%
3 Financials 16.07%
4 Energy 13.85%
5 Consumer Staples 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEM icon
176
Newmont
NEM
$121B
-3,200
Closed -$96K
PEP icon
177
PepsiCo
PEP
$191B
-4,100
Closed -$335K
ROK icon
178
Rockwell Automation
ROK
$49.6B
-2,400
Closed -$200K
TER icon
179
Teradyne
TER
$63.7B
-6,900
Closed -$121K
USNA icon
180
Usana Health Sciences
USNA
$249M
-4,000
Closed -$145K
XLS
181
DELISTED
EXELIS INC COM STK
XLS
-11,995
Closed -$154K
SWY
182
DELISTED
SAFEWAY INC
SWY
-14,186
Closed -$300K
BZ
183
DELISTED
BOISE INC COM STK (DE)
BZ
-8,757
Closed -$75K
SFD
184
DELISTED
SMITHFIELD FOODS,INC
SFD
-20,900
Closed -$684K
BKI
185
DELISTED
BUCKEYE TECHNOLOGY INC
BKI
-22,000
Closed -$815K
NITE
186
DELISTED
KNIGHT CAPITAL GROUP, INC. CLASS A
NITE
-5,800
Closed -$21K
LXK
187
DELISTED
Lexmark Intl Inc
LXK
-10,900
Closed -$333K

Similar funds

Livforsakringsbolaget Skandia's Q3 2013 Portfolio in Review

As of Q3 2013, Livforsakringsbolaget Skandia held 187 positions worth $145M, up 4.2% from $139M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Livforsakringsbolaget Skandia's Q3 2013 filing shows 12 new, 18 increased, 17 reduced and 19 closed positions. Its largest new stake was United Therapeutics: 10,403 shares worth $820K. The largest sale was Pfizer, an estimated $1.14M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Livforsakringsbolaget Skandia's largest Q3 2013 buy was United Therapeutics: 10,403 shares worth $820K.
  • Livforsakringsbolaget Skandia added most to ExxonMobil in Q3 2013, an estimated $1.22M increase.
  • Livforsakringsbolaget Skandia's biggest Q3 2013 reduction was Pfizer, cutting an estimated $1.14M.
  • Livforsakringsbolaget Skandia fully exited BUCKEYE TECHNOLOGY INC in Q3 2013, selling an estimated $815K.
  • Livforsakringsbolaget Skandia's ten largest holdings make up 24% of its $145M portfolio in Q3 2013.
  • Livforsakringsbolaget Skandia opened 12 new positions and closed 19 in Q3 2013.
  • Livforsakringsbolaget Skandia's portfolio value rose 4.2% quarter-over-quarter to $145M.

Based on Livforsakringsbolaget Skandia's 13F filing for Q3 2013, filed 16 Oct 2013.